Time | Topic | |
---|---|---|
0800 – 0825 | Registration | |
0825 – 0830 | Welcome Address | |
|
Welcome Address | |
0830 – 0950 | Esophageal HRM I | |
|
Introduction to Esophageal HRM | |
|
Practical Session: 3 HRM Cases | |
0950 – 1020 | Morning Tea Break | |
1020 – 1200 | Esophageal HRM II | |
|
Clinical Application of Esophageal HRM | |
|
Practical Session | |
|
Case Discussion | |
1200 – 1300 | Lunch Symposium | |
|
ROME VS Asian Functional Esophageal Disorder | |
1300 – 1400 | Esophageal pH and Impedance I | |
|
Introduction Esophageal pH and Impedance Monitoring | |
|
Update on Sandhill Zvu Analysis Software | |
|
Practical Session: 2 Cases | |
1440 – 1510 | Afternoon Tea Break | |
1510 – 1650 | Esophageal pH and Impedance II | |
|
Clinical Application fo Esophageal pH and Impedance Monitoring | |
|
Practical Session: 2 Cases | |
|
Case Discussion | |
1650 – 1700 | Closing | |
|
Closing Remarks | |
End of Course |
Time | Topic | |
---|---|---|
0800 – 0900 | Registration | |
0900 – 1035 | Session I | |
|
Welcome Address | |
|
Pre-Course Picture Quiz | |
|
Endoscopic Evaluation of Early Gastric Neoplasia | |
|
Endoscopic Evaluation of Early Esophageal Neoplasia | |
|
New Imaging Modalities in Assessing Upper GI Lesions | |
0945 – 1005 Linked Color Imaging and Blue Light Imaging | ||
1005 – 1025 iScan and Optical Enhancement | ||
|
Question and Answer Sesion | |
1035 – 1100 | Tea Break | |
1100 – 1235 | Session II | |
|
Management of Early Duodenal Lesions | |
|
Endoscopic Management of Early Upper GI Neoplasia | |
|
How to Perform Detailed OGD the Japanese Way | |
|
Post-Course Picture Quiz | |
|
Question and Answer Session | |
|
Closing Remarks and Photo Taking | |
End of Course |
Time | Topic | |
---|---|---|
1230 – 1300 | Registration | |
1300 – 1450 | Session I | |
|
Welcome Address | |
|
Epidemiology of NAFLD in Asia | |
|
Best Non-Invasive Screening Modality for NAFLD | |
|
Debate: Do We Really Need Liver Biopsy in NASH Management? | |
|
Endocrinologist’s Take on Fatty Liver | |
1450 – 1520 | Afternoon Tea Break | |
1520 – 1700 | Sesion II | |
|
Management of NAFLD – State of the Art | |
|
NASH HCC | |
|
Role of Liver Supplements in NAFLD; To Use or Not to Use? | |
|
Liver Transplantation in NAFLD and Obese Patients | |
End of Course |
Time | Topic | Speaker/Chairperson | |
---|---|---|---|
0800 – 0830 | Registration | ||
0830 – 0840 | Welcome Address | ||
|
Welcome Address by Course Director | ||
0840 – 0900 | Endoscopy Lecture I | ||
|
EUS Management of Gastric Outlet Obstruction | ||
0900 – 1010 | Live Endoscopy Demostration Session I | ||
1010 – 1030 | Morning Tea Break | ||
1030 – 1050 | Endoscopy Lecture II | ||
|
Endoscopic Management of Colorectal Polyps | ||
1050 – 1200 | Live Endoscopy Demostration Session II | ||
1200 – 1330 | Lunch and Tour of Exhibition | ||
1330 – 1350 | Endoscopy Lecture III | ||
|
Power Spiral – A New Way of Examining the Small Bowel | ||
1350 – 1500 | Live Endoscopy Demostration Session III | ||
1500 – 1520 | Afternoon Tea Break | ||
1520 – 1540 | Endoscopy Lecture IV | ||
|
Guest Lecture: Progress of Advanced Endoscopic Resection in the West | ||
1540 – 1650 | Live Endoscopy Demostration Session IV | ||
1650 – 1730 | Video Case Presentations | ||
|
Case 1 Presentation | ||
|
Case 2 Presentation | ||
|
Case 3 Presentation | ||
|
Case 4 Presentation | ||
1730 – 1740 | Closing | ||
|
Closing Remarks by Course Director | ||
END OF ENDOSCOPY WORKSHOP | |||
1930 – 2130 | Faculty Dinner (Faculty and Invited Guests Only) |
Time | Topic | Speaker/Chairperson | |
---|---|---|---|
0820 – 0850 | Registration | ||
0850 – 0950 | Free Paper Presentations | ||
|
Free Paper 1 | ||
|
Free Paper 2 | ||
|
Free Paper 3 | ||
|
Free Paper 4 | ||
|
Free Paper 5 | ||
|
Free Paper 6 | ||
0950 – 1050 | Morning Tea Break & Poster Round | ||
1050 – 1230 | Liver Symposium I | ||
|
State-of-the-Art Lecture: The Cure for Hepatitis B | ||
|
Ask the Expert | ||
|
Management of Cirrhosis in 2019 | ||
|
Help! Does my Patient Need a Liver Transplant Now? | ||
1230 – 1345 | Lunch | ||
|
Lunch Symposium Sponsored by Gilead | ||
|
Reducing the Risk of Long-Term Liver Disease | ||
|
Reducing the Risks when Treating Patients with CHB | ||
|
Question and Answer Session | ||
|
Lunch (continuation) and Viewing of Posters and Exhibitions | ||
1345 – 1400 | Opening Ceremony | ||
|
Welcome Address by Scientific Chair, GESS | ||
|
Welcome Address by Chairman Nursing Chapter, GESS | ||
|
Opening Address by President, GESS | ||
1400 – 1500 | Plenary Session | ||
|
Seah Cheng Siang Memorial Oration | ||
|
Plenary Lecture: Evolution of Management Functional Dyspepsia | ||
1500 – 1530 | Afternoon Tea Break | ||
1530 – 1700 | IBD Symposium – The Future is NOW | ||
|
Therapy with Biologics in the Current Era – Is There Still a Role for Immunomodulators? Combo Versus Mono Therapy | ||
|
Asia-Pacific IBD Consensus | ||
|
Debate – Dysplasia in UC: Endoscopic Resection and Surveillance – Why Delay the Inevitable? | ||
|
Fireside Chat – FMT Therapy in IBD: The Nuts and Bolts of FMT in IBD | ||
1700 – 1800 | GESS AGM (For GESS Members ONLY) | ||
1730 – 1830 | Conference Dinner Cocktail | ||
1830 – 1900 | Evening Symposium | ||
|
Evening Symposium Sponsored by AstraZeneca | ||
1900 – 2100 | GIHep Conference Dinner and Award Presentations | ||
|
Prize and Award Presentation | ||
Award Presentation – Doctors Category | |||
Award Presentation – Nursing Category | |||
1915 – 2100 | Conference Dinner |
Time | Topic | Speaker/Chairperson | |
---|---|---|---|
0800 – 0830 | Registration | ||
0830 – 1000 | Motility Symposium | ||
|
Debate: Are GI Motility Investigations Necessary for Patient Care? | ||
|
Clinical Measurement of Gastrointestinal Motility and Function: Who, When and Which Test? | ||
|
Belching, Bloating and Flatulence: Management of Difficult Abdominal Gas Syndrome | ||
|
Question and Answer Session | ||
1000 – 1030 | Morning Tea Break | ||
|
Morning Tea Break Symposium (Sponsored by BMS) | ||
1030 – 1200 | Liver Symposium II | ||
|
Immuno-Oncology Related Liver Diseases | ||
|
NAFLD in Viral Hepatitis | ||
|
Is My Cirrhotic Patient Really Coagulopathic? | ||
|
Question and Answer Session | ||
|
Abstract Presentation | ||
1200 – 1315 | Lunch | ||
|
Lunch Symposium (Sponsored by Takeda) | ||
|
Lunch (continuation) and viewing of posters and exhibitions | ||
1315 – 1445 | Upper GI Symposium | ||
|
Immuno-Oncology Related GI Diseases | ||
|
Upper GI Bleed | ||
|
Things are Moving Forward in Gastroparesis: Evolving Management Options | ||
|
Recent Advances in Diagnosis and Management of Gastric Cancer | ||
|
Question and Answer Session | ||
1445 – 1515 | Afternoon Tea Break | ||
1515 – 1650 | Endoscopy Symposium | ||
|
ABCs of Diagnosing Early Upper GI Cancer | ||
|
Clinical Application and Utility of EUS-Guided Ablative Therapy | ||
|
Management Approach to Small Bowel Disease in the Horizon | ||
|
EMR or ESD: When and How? | ||
|
Question and Answer Session | ||
1650 – 1700 | Closing | ||
|
Closing Remarks by President | ||
End of Meeting |
Time | Topic | Speaker/Chairperson | |
---|---|---|---|
1245 – 1400 | Registration & Lunch | ||
1400 – 1510 | Symposium I | ||
|
GP Plenary Lecture: Colorectal Cancer Screening in Singapore | ||
|
PPIs and Beyond | ||
|
Bloating and Burping | ||
1510 – 1540 | Afternoon Tea Break | ||
1540 – 1640 | Symposium II | ||
|
Abnormal Hepatobiliary Ultrasound | ||
|
Update on Fatty Liver | ||
|
Tumour Markers: Should We be Doing Them? | ||
End of GP Symposium |